Primary endpoint analysis of the GEPARDUO study: Comparing dose-dense with sequential adriamycin/docetaxel combination as preoperative chemotherapy (PCHT) in operable breast cancer (T2-3, N0-2, M0)

✍ Scribed by A. Loehr; G. von Minckwitz; G. Raab; M. Schuette; J.U. Blohmer; J. Hilfrich; B. Gerber; S.B. Costa; A. Caputo; M. Kaufmann

• Book ID: 114315643
• Publisher: Elsevier Science
• Year: 2003
• Tongue: English
• Weight: 201 KB
• Volume: 12
• Category: Article
• ISSN: 0960-9776
• DOI: 10.1016/s0960-9776(03)80118-2